Robert Fried is Chief Executive Officer of Niagen Bioscience, Inc. (NAGE). The company reported total compensation of $8,381,900 for fiscal year 2025.
| Salary | $645,962 |
|---|---|
| Bonus | $0 |
| Stock awards | $5,220,188 |
| Option awards | $1,949,648 |
| Non-equity incentive plan | $565,378 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $724 |
| Total | $8,381,900 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Niagen Bioscience, Inc. filed April 29, 2026, accession 0001386570-26-000022.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $645,962 | $0 | $5,220,188 | $1,949,648 | $565,378 | $0 | $724 | $8,381,900 |
| FY2024 | Chief Executive Officer | $500,000 | $0 | $0 | $424,898 | $286,497 | $0 | $736 | $1,212,131 |
| FY2023 | Chief Executive Officer | $500,000 | $0 | $0 | $391,249 | $268,221 | $0 | $736 | $1,160,206 |
Totals as disclosed in each year's own compensation disclosure for Niagen Bioscience, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Robert Fried this page | Chief Executive Officer | $8,381,900 |
| Ozan Pamir | Chief Financial Officer | $716,475 |
| Carlos Lopez | SVP, General Counsel | $558,014 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Niagen Bioscience, Inc. compensation brief.
Robert Fried's compensation sits inside Niagen Bioscience, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.